March 8, 2022
Medsafe has granted Paxlovid™ (nirmatrelvir/ritonavir tablets) provisional consent for the treatment of coronavirus disease 2019 (COVID-19) in adults 18 years of age and older, who do not require initiation of supplemental oxygen due to COVID-19 and are at increased risk of progression to hospitalisation or death.